Primary |
Pulmonary Arterial Hypertension |
36.0% |
Pulmonary Hypertension |
23.1% |
Product Used For Unknown Indication |
20.2% |
Drug Use For Unknown Indication |
8.9% |
Cor Pulmonale Chronic |
3.9% |
Cardiac Failure |
2.0% |
Essential Hypertension |
0.8% |
Pain |
0.7% |
Prophylaxis |
0.6% |
Right Ventricular Failure |
0.6% |
Connective Tissue Disorder |
0.5% |
Cough |
0.4% |
Collagen Disorder |
0.3% |
Sedation |
0.3% |
Postoperative Care |
0.3% |
Eisenmenger's Syndrome |
0.3% |
Heart Disease Congenital |
0.3% |
Hypertension |
0.3% |
Infection Prophylaxis |
0.3% |
Pulmonary Embolism |
0.3% |
|
Death |
18.8% |
Pharmaceutical Product Complaint |
17.6% |
Vomiting |
5.6% |
Pneumonia |
5.2% |
Pain In Jaw |
5.0% |
Dyspnoea |
4.2% |
Pyrexia |
3.9% |
Thrombocytopenia |
3.9% |
Rash |
3.8% |
Device Related Infection |
3.4% |
Diarrhoea |
3.4% |
Weight Increased |
3.4% |
Weight Decreased |
3.1% |
Pulmonary Hypertension |
3.0% |
Pain In Extremity |
2.8% |
Medical Device Complication |
2.7% |
Platelet Count Decreased |
2.7% |
Right Ventricular Failure |
2.7% |
Tachycardia |
2.6% |
Ascites |
2.4% |
|
Secondary |
Pulmonary Arterial Hypertension |
33.5% |
Pulmonary Hypertension |
18.4% |
Product Used For Unknown Indication |
8.5% |
Prophylaxis |
4.1% |
Cor Pulmonale Chronic |
4.0% |
Drug Use For Unknown Indication |
4.0% |
Cough |
4.0% |
Prophylaxis Against Gastrointestinal Ulcer |
3.0% |
Thrombosis Prophylaxis |
2.8% |
Infection Prophylaxis |
2.7% |
Osteoporosis Prophylaxis |
2.7% |
Anxiety |
2.1% |
Diarrhoea |
2.1% |
Prophylaxis Against Diarrhoea |
2.1% |
Cardiac Failure |
1.9% |
Right Ventricular Failure |
1.1% |
Primary Pulmonary Hypertension |
1.0% |
Collagen Disorder |
0.9% |
Ill-defined Disorder |
0.6% |
Hyperthyroidism |
0.5% |
|
Pneumonia |
18.6% |
Death |
15.3% |
Pulmonary Congestion |
7.6% |
White Blood Cell Count Decreased |
5.5% |
Urticaria |
5.1% |
Ventricular Tachycardia |
5.1% |
Vomiting |
4.7% |
Weight Decreased |
4.7% |
Device Related Infection |
3.4% |
Pain In Extremity |
3.4% |
Cardiac Failure |
3.0% |
Lung Transplant |
3.0% |
Pulmonary Alveolar Haemorrhage |
3.0% |
Pulmonary Hypertension |
3.0% |
Thrombocytopenia |
3.0% |
Treatment Noncompliance |
3.0% |
Right Ventricular Failure |
2.5% |
Coronary Artery Disease |
2.1% |
Hypotension |
2.1% |
Sinus Rhythm |
2.1% |
|
Concomitant |
Pulmonary Arterial Hypertension |
45.2% |
Pulmonary Hypertension |
22.0% |
Product Used For Unknown Indication |
18.5% |
Prophylaxis |
1.3% |
Vitamin Supplementation |
1.1% |
Cardiac Failure |
1.1% |
Pain |
1.1% |
Drug Use For Unknown Indication |
1.0% |
Anticoagulant Therapy |
0.9% |
Asthma |
0.9% |
Right Ventricular Failure |
0.8% |
Arrhythmia |
0.8% |
Immunosuppression |
0.8% |
Cor Pulmonale Chronic |
0.7% |
Scleroderma |
0.7% |
Coronary Artery Bypass |
0.6% |
Hypokalaemia |
0.6% |
Pneumonia |
0.6% |
Rheumatoid Arthritis |
0.6% |
Infection Prophylaxis |
0.6% |
|
Death |
14.9% |
Right Ventricular Failure |
13.4% |
Vomiting |
7.8% |
Pulmonary Arterial Hypertension |
7.5% |
Cardiac Failure |
5.6% |
Device Related Infection |
5.6% |
Dyspnoea |
4.3% |
Pulmonary Hypertension |
4.3% |
Pneumonia |
4.0% |
Pregnancy |
3.7% |
Hepatic Function Abnormal |
3.4% |
Syncope |
3.4% |
Lung Transplant |
3.1% |
Nausea |
3.1% |
Oedema |
3.1% |
Thrombocytopenia |
2.8% |
Chest Pain |
2.5% |
Oedema Peripheral |
2.5% |
Restlessness |
2.5% |
Scleroderma |
2.5% |
|
Interacting |
Pulmonary Hypertension |
100.0% |
|
Rash |
50.0% |
Vomiting |
50.0% |
|